BNTC
Benitec Biopharma Ltd
9.60$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -257.3% | – | – | – | – | – | – | |
| – | +62.4% | – | – | +126.0% | +11.8% | -23.0% | +117.0% | +56.7% | – | – | +472.3% | -84.7% | +1,808.8% | -34.3% | +10.9% | +136.7% | +13.4% | -7.5% | -2.8% | -10.0% | +15.5% | +21.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -75.2% | +167.5% | +37.2% | -48.0% | +83.6% | +1,999.5% | +51.6% | |
| – | – | – | – | – | – | – | – | – | – | – | -9.2% | +750.9% | -77.2% | -45.0% | +98.3% | -65.9% | +158.6% | +42.4% | -48.3% | – | – | – | |
| – | – | -882.0% | – | -180.3% | – | -72.9% | +1,038.9% | -273.0% | – | -4,923.5% | – | -59.1% | +116.5% | +95.7% | -11.0% | -90.5% | -93.7% | +12,862.5% | -31.1% | +64.4% | -332.5% | – | |
| – | +1,319.3% | -98.5% | -29.5% | +20.6% | -98.4% | +1,489.2% | +873.9% | -29.3% | +60.7% | +1,528.1% | -18.5% | -34.1% | -48.5% | -53.6% | +561.6% | -76.4% | +132.6% | -94.1% | -92.3% | +17,800.0% | -89.9% | +483.3% | |
| – | +132.5% | -98.4% | -29.5% | +20.6% | -98.4% | +1,495.2% | +876.1% | -29.3% | – | -121.3% | +1,126.8% | -11.7% | -11.7% | -51.3% | +171.6% | -76.5% | +135.1% | -94.1% | -92.3% | +17,800.0% | -89.9% | +483.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -99.0% | +4,955.1% | -58.5% | +9.3% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.0% | -79.5% | +77.4% | -99.8% | +14,895.9% | -40.7% | +625.3% | -104.8% | – | +3,062.9% | -99.9% | +30,644.1% | -54.7% | +7.2% | -108.1% | – | +1,172.4% | -28.9% | +0.0% | +324.8% | +3.6% | +40.4% | |
| – | – | – | +360.4% | -200.2% | – | – | – | -160.1% | – | – | -124.5% | – | – | – | – | -233.6% | – | -257.6% | – | – | -3.1% | +75.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -273.9% | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.